FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101837 [Registered on: 22/01/2026] Trial Registered Prospectively
Last Modified On: 22/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   COMPARING THE EFFECT OF EXPOSURE TO INHALED BUDESONIDE VERSUS FLUTICASONE PROPIONATE IN PARTICIPANTS UNDERGOING ELECTIVE INTUBATION ON POST OPERATIVE SORE THROAT, COUGH, AND HOARSENESS OF VOICE 
Scientific Title of Study   COMPARING THE EFFICACY OF INHALED BUDESONIDE SUSPENSION VERSUS INHALED FLUTICASONE PROPIONATE ADMINISTERED USING A METERED DOSE INHALER, ON POST- OPERATIVE SORE THROAT, HOARSENESS OF VOICE AND COUGH AN OBSERVATIONAL STUDY.” 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rinka Pal 
Designation  Junior Resident-2 
Affiliation  Grant Government Medical college and Sir J J Hospital.  
Address  Department of anaesthesia, J J Hospital campus. Bycualla 400008
Department of anaesthesia, J J Hospital campus. Bycualla 400008
Mumbai
MAHARASHTRA
400008
India 
Phone  8390719333  
Fax    
Email  rinka.pal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sukriti Atram 
Designation  Associate Professor 
Affiliation  Grant Government Medical college and Sir J J Hospital.  
Address  Department of Anaesthesiology, Grant Government Medical college and Sir J J Hospital.
Department of Anaesthesiology, Grant Government Medical college and Sir J J Hospital.
Mumbai
MAHARASHTRA
400008
India 
Phone  9004083034  
Fax    
Email  sukritiatram@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sukriti Atram 
Designation  Associate Professor 
Affiliation  Grant Government Medical college and Sir J J Hospital.  
Address  Department of Anaesthesiology, Grant Government Medical college and Sir J J Hospital.
Department of Anaesthesiology, Grant Government Medical college and Sir J J Hospital.
Mumbai
MAHARASHTRA
400008
India 
Phone  9004083034  
Fax    
Email  sukritiatram@yahoo.co.in  
 
Source of Monetary or Material Support  
Department of Anaesthesiology Grant Government Medical College and Sir J J Hospital, Byculla Mumbai 400008 
 
Primary Sponsor  
Name  DrRinka Pal 
Address  Department of anaesthesia, J J Hospital campus. Bycualla 400008 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Rinka Pal  Grant Government Medical College and Sir J J Hospital,   Department of anaesthesia.
Mumbai
MAHARASHTRA 
08390719333

rinka.pal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute of Ethics Committe, Grant Government Medical College,Mumbai 400008e  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  INHALED BUDESINIDE MDI  COMPARING THE EFFICASY ON POST ENDOTRACHEAL INTUBATION ON POST OPERATIVE SORE THROAT, HOARSENESS OF VOICE AND COUGH 
Intervention  INHALED FLUTICASONE PROPIONATE MDI  COMPARING THE EFFICASY ON POST ENDOTRACHEAL INTUBATION ON POST OPERATIVE SORE THROAT, HOARSENESS OF VOICE AND COUGH 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA grade I (healthy patients) and II (mild to moderate systemic disease but medically well controlled).
Patients posted for elective surgeries in Operation theater.
Patients who are MPC 1(complete visualization of uvula)) or 2 (uvula partly visible) as assessed by a senior anesthetist.
 
 
ExclusionCriteria 
Details  Patients with known allergy to corticosteroid.
Patients who are not willing to participate in this study.
Patients with pre-existing cardiovascular, renal and hepatic disorders.
Patients who have difficult airways as assessed by a senior anesthetist (obese (BMI MORE THAN 30 kg/meter sq), distorted airways.
Patients who are anticipated difficult intubation.
Patients already on analgesic or steroids (systemic or inhaled).
Patients with pre-operative sore throat.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
TO COMPARE THE EFFECTIVENESS OF INHALED BUDESONIDE SUSPENSION VERSUS INHALED FLUTICASONE PROPIONATE (ADMINISTERED VIA METERED-DOSE INHALER) IN REDUCING THE INCIDENCE AND SEVERITY OF POST-OPERATIVE SORE THROAT (POST).  ASSESSED AT BASELINE (POST EXTUBATION), 2HOURS, 4 HOURS, 6 HOURS, 12HOURS, AND AT 24 HOURS 
 
Secondary Outcome  
Outcome  TimePoints 
TO EVALUATE THE EFFECT OF INHALED BUDESONIDE AND INHALED FLUTICASONE PROPIONATE ON THE HEMODYNAMIC CHANGES   ASSESSED AT BASELINE AFTER INDUCTION, POST INDUCTION, 15 MINUTES, 30 MINUTES, 45 MINUTES, 60 MINUTES, 90 MINUTES,120 MINUTES, BEFORE EXTUBATION, IMMEDIATELY POST EXTUBATION. 
 
Target Sample Size   Total Sample Size="104"
Sample Size from India="104" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/12/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

THIS PROSPECTIVE COMPARATIVE STUDY IS DESIGNED TO ASSESS AND COMPARE THE EFFICACY OF INHALED BUDESONIDE SUSPENSION (200 MCG) AND INHALED FLUTICASONE PROPIONATE (150 MCG) DELIVERED VIA A METERED-DOSE INHALER 10 MINUTES PRIOR TO ENDOTRACHEAL INTUBATION, IN REDUCING THE INCIDENCE AND SEVERITY OF POST-OPERATIVE SORE THROAT, COUGH, AND HOARSENESS OF VOICE IN PATIENTS UNDERGOING GENERAL ANAESTHESIA.

A TOTAL OF 104 PATIENTS WITH ASA PHYSICAL STATUS I–II, AGED 18–60 YEARS, WILL BE RANDOMLY ASSIGNED TO TWO GROUPS. POST-OPERATIVE SORE THROAT, COUGH, AND HOARSENESS WILL BE EVALUATED AT 2, 4, 6, 12, AND 24 HOURS FOLLOWING SURGERY USING STANDARDIZED GRADING CRITERIA. HEMODYNAMIC VARIABLES AND ANY DRUG-RELATED ADVERSE EFFECTS WILL ALSO BE MONITORED AND DOCUMENTED.

THE STUDY IS ANTICIPATED TO DEMONSTRATE THAT BOTH INHALED CORTICOSTEROIDS ARE EFFECTIVE IN REDUCING AIRWAY-RELATED POST-OPERATIVE COMPLICATIONS, WITH EITHER SIMILAR EFFICACY OR A STATISTICALLY SIGNIFICANT DIFFERENCE BETWEEN THE TWO AGENTS. THE FINDINGS MAY HELP DETERMINE A SAFE AND EFFECTIVE PROPHYLACTIC INTERVENTION FOR MINIMIZING POST-INTUBATION AIRWAY MORBIDITY.

 
Close